{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:45:29Z","timestamp":1776512729386,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine Reports"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.pmedr.2026.103463","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:55:14Z","timestamp":1775231714000},"page":"103463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hyperlipidemia and associated risk factors among people living with HIV on antiretroviral therapy: a retrospective cohort study from Eastern China"],"prefix":"10.1016","volume":"65","author":[{"given":"Wei","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiezhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengliang","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmedr.2026.103463_bb0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/QAI.0b013e318219a3d1","article-title":"Dyslipidemia in an HIV-positive antiretroviral treatment-naive population in Dar Es Salaam, tanzania","volume":"57","author":"Armstrong","year":"2011","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.pmedr.2026.103463_bb0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/DHPS.S395037","article-title":"Prevalence and factors associated with dyslipidemia among people living with HIV\/AIDS on follow-up care at a tertiary care hospital in Ethiopia: a cross-sectional study","volume":"15","author":"Assefa","year":"2023","journal-title":"Drug, Healthcare Patient Saf."},{"key":"10.1016\/j.pmedr.2026.103463_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12981-022-00467-y","article-title":"Prevalence and risk factors of high cholesterol and triglycerides among people with HIV in Texas","volume":"19","author":"Buendia","year":"2022","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.pmedr.2026.103463_bb0020","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/QAD.0000000000002811","article-title":"Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents","volume":"35","author":"Byonanebye","year":"2021","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.pmedr.2026.103463_bb0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ecl.2022.02.010","article-title":"Hypertriglyceridemia","volume":"51","author":"Chait","year":"2022","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.pmedr.2026.103463_bb0030","article-title":"Characteristics and factors associated with initial antiretroviral medicine use among newly treated HIV\/AIDS patients in Zhejiang Province, Eastern China: a cross-sectional study","volume":"55","author":"Chen","year":"2025","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.pmedr.2026.103463_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12944-020-1189-y","article-title":"Associations between age and dyslipidemia are differed by education level: the cardiovascular and metabolic diseases etiology research center (CMERC) cohort","volume":"19","author":"Cho","year":"2020","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.pmedr.2026.103463_bb0040","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/1570162X17666191025115508","article-title":"Impact of Lopinavir\/ritonavir and Efavirenz-based antiretroviral therapy on the lipid profile of chinese HIV\/AIDS treatment-na\u00efve patients in Beijing: a retrospective study","volume":"17","author":"Dai","year":"2019","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.pmedr.2026.103463_bb0045","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-M\u00f8ller","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pmedr.2026.103463_bb0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11904-016-0321-0","article-title":"Lipid abnormalities and inflammation in HIV inflection","volume":"13","author":"Funderburg","year":"2016","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.pmedr.2026.103463_bb0055","first-page":"95","article-title":"Prevalence of dyslipidemia and influencing factors in HIV-infected people before starting antiretroviral therapy in China, 2018-2023","volume":"46","author":"Jia","year":"2025","journal-title":"Chin. J. Epidemiol."},{"key":"10.1016\/j.pmedr.2026.103463_bb0060","first-page":"237","article-title":"Chinese guidelines for lipid management (2023)","volume":"38","author":"Jianjun","year":"2023","journal-title":"Chin. J. Cardiol."},{"key":"10.1016\/j.pmedr.2026.103463_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19148272","article-title":"Serum cholesterol levels and risk of cardiovascular death: a systematic review and a dose-response Meta-analysis of prospective cohort studies","volume":"19","author":"Jung","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.pmedr.2026.103463_bb0070","first-page":"221","article-title":"Dyslipidemia and associated factors among adult patients on antiretroviral therapy in Armed Force Comprehensive and Specialized Hospital, Addis Ababa, Ethiopia","volume":"12","author":"Kemal","year":"2020","journal-title":"HIV\/AIDS (Auckland, N.Z.)"},{"key":"10.1016\/j.pmedr.2026.103463_bb0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/2325957414555227","article-title":"Dyslipidemia in ART-naive HIV-infected persons in Nigeria--implications for care","volume":"14","author":"Kuti","year":"2015","journal-title":"J. Int. Assoc. Provid. AIDS Care"},{"key":"10.1016\/j.pmedr.2026.103463_bb0080","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/QAD.0000000000001837","article-title":"Increased cholesterol absorption rather than synthesis is involved in boosted protease inhibitor-associated hypercholesterolaemia","volume":"32","author":"Leyes","year":"2018","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.pmedr.2026.103463_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-023-08587-0","article-title":"Risk factors and longitudinal changes of dyslipidemia among chinese people living with HIV receiving antiretroviral therapy","volume":"23","author":"Li","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.pmedr.2026.103463_bb0090","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/ije\/dyp233","article-title":"Cohort profile: the chinese national free antiretroviral treatment cohort","volume":"39","author":"Ma","year":"2010","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.pmedr.2026.103463_bb0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(23)01381-8","article-title":"HIV epidemiology, prevention, treatment, and implementation strategies for public health","volume":"403","author":"Mody","year":"2024","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pmedr.2026.103463_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-023-08910-9","article-title":"Dyslipidemia among HIV-infected patients in Ethiopia: a systematic review and meta-analysis","volume":"24","author":"Mohammed","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.pmedr.2026.103463_bb0105","doi-asserted-by":"crossref","DOI":"10.1177\/2325958219841908","article-title":"Comparative assessment of the magnitude of hyperlipidemia in HIV-infected patients receiving lopinavir\/r- and atazanavir\/r-based antiretroviral drugs","volume":"18","author":"Muya","year":"2019","journal-title":"J. Int. Assoc. Provid. AIDS Care"},{"key":"10.1016\/j.pmedr.2026.103463_bb0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2016.03.016","article-title":"Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: a systematic review and meta-analysis","volume":"248","author":"Peters","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pmedr.2026.103463_bb0115","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1097\/CM9.0000000000001245","article-title":"Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen","volume":"133","author":"Sun","year":"2020","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.pmedr.2026.103463_bb0120","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/QAI.0000000000003040","article-title":"Higher risk of dyslipidemia with coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide than efavirenz, lamivudine, and tenofovir disoproxil fumarate among antiretroviral-naive people living with HIV in China","volume":"91","author":"Sun","year":"2022","journal-title":"J. Acquir. Immune Defic. Syndr. (1999)"},{"key":"10.1016\/j.pmedr.2026.103463_bb0125","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1161\/CIR.0000000000000240","article-title":"Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 4: congenital heart disease: a scientific statement from the american heart association and american college of cardiology","volume":"132","author":"Van Hare","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.pmedr.2026.103463_bb0130","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/CM9.0000000000003147","article-title":"Changes in blood lipid levels and influencing factors among treatment-na\u00efve adult male HIV\/AIDS patients following BIC\/FTC\/TAF vs. 3TC+EFV+TDF","volume":"137","author":"Wang","year":"2024","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.pmedr.2026.103463_bb0135","first-page":"249","article-title":"Lipid abnormalities in persons living with HIV infection","volume":"35","author":"Waters","year":"2019","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.pmedr.2026.103463_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1498165","article-title":"The prevalence of dyslipidemia and its correlation with anti-retroviral therapy among people living with HIV in China: a systematic review and meta-analysis","volume":"12","author":"Wenjing","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.pmedr.2026.103463_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-023-01786-3","article-title":"Incidence and risk factors of hypertriglyceridemia in males with human immunodeficiency virus who are treated with combination antiretroviral therapy: a retrospective cohort study","volume":"22","author":"Yu","year":"2023","journal-title":"Lipids Health Dis."},{"issue":"Suppl. 8","key":"10.1016\/j.pmedr.2026.103463_bb0150","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1097\/01.aids.0000304710.10036.2b","article-title":"The chinese free antiretroviral treatment program: challenges and responses","volume":"21","author":"Zhang","year":"2007","journal-title":"AIDS (London, England)"}],"container-title":["Preventive Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335526000914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335526000914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:10:11Z","timestamp":1776510611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211335526000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":30,"alternative-id":["S2211335526000914"],"URL":"https:\/\/doi.org\/10.1016\/j.pmedr.2026.103463","relation":{},"ISSN":["2211-3355"],"issn-type":[{"value":"2211-3355","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperlipidemia and associated risk factors among people living with HIV on antiretroviral therapy: a retrospective cohort study from Eastern China","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmedr.2026.103463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103463"}}